Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06710678 · ClinicalTrials.gov registry record · NA
Examining Executive Functions in Medical Students Across Different Types of Study Breaks
A NA study of Executive Function (Cognition), sponsored by New York Institute of Technology.
- Recruiting
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06710678: Recruiting NA study of Executive Function (Cognition), sponsored by New York Institute of Technology.
NCT06710678 is a NA study of Executive Function (Cognition) that is actively recruiting participants, run by New York Institute of Technology. The registered enrollment target is 120 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06710678, a NA study of Executive Function (Cognition), is actively recruiting participants, sponsored by New York Institute of Technology.
- RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to expand on previous findings and compare the effects of an active break (ten minutes of walking or upper body movement), a digital break (ten minutes of phone use), and no break on memory and attention in medical students after a prolonged period of studying. The List Learning Task, Stroop Test, and Sustained Attention to Response Task will be administered to measure memory, executive function, and attention, respectively. Information on how different types of breaks affect memory and attention may prompt medical students to be more mindful and intentional of the way they spend their time in between studying.
Primary Outcome
Sustained Attention to Response Task is a go/nogo task with infrequent nogo signals to measure attention. Participants are presented with a single digit 1-9 in the middle of the screen in varying font sizes. The digit disappears after a short while and is replaced with a mask (circle with an X). Participants are asked to press the SPACEBAR if any digit other than 3 is presented and to withhold the response if digit 3 is presented.
Conditions Studied
Interventions
- BEHAVIORAL Physical Activity Study Break
- BEHAVIORAL Social Media Study Break
Study Locations (1)
New York
- NYIT - Old Westbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-11-19 |
| Est. Completion | 2025-08-01 |
| Phase | NA |
What NCT06710678 shows while recruiting
NCT06710678 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (91% lower).
The record links to 1 condition, with Executive Function (Cognition) appearing as the primary indexed condition, and to 2 interventions - of which Physical Activity Study Break is the first listed.
NCT06710678 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06710678 about?
NCT06710678 is a clinical study titled "Examining Executive Functions in Medical Students Across Different Types of Study Breaks". This study aims to expand on previous findings and compare the effects of an active break (ten minutes of walking or upper body movement), a digital break (ten minutes of phone use), and no break on memory and attention in medical students after a prolonged period of studying. The List Learning Task...
What is the current status of trial NCT06710678?
This trial is currently recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2024-11-19. Estimated completion is 2025-08-01.
What conditions does trial NCT06710678 study?
This clinical trial studies the following conditions: Executive Function (Cognition).
What interventions are being tested in trial NCT06710678?
The interventions under investigation include: Physical Activity Study Break (BEHAVIORAL), Social Media Study Break (BEHAVIORAL).
Who is sponsoring clinical trial NCT06710678?
This trial is sponsored by New York Institute of Technology, which has 49 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06710678 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Executive Function (Cognition)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06710678's enrollment target sits among peer trials
120 762nd of 2000 higher than 1,198 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI